A new fitness event has crossed the starting line to support Hôtel-Dieu Grace Healthcare, stepping in to replace the popular ...

Dear Shareholders, It continues to be a transformative year for CytoDyn Inc. ("CytoDyn" or the "Company"). A year in which we have made significant ...

1, the parent strain of the most common currently circulating variants. The Food and Drug Administration (FDA) has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 ...

The Putative Fidgetin Like Protein 2 pipeline drugs market research report outlays comprehensive information on the Putative Fidgetin Like Protein 2 targeted therapeutics, complete with analysis by ...

It was a busy week for the biotech sector, with a lot of important data readouts and regulatory updates. Among these, Novavax ...

Novavax touts that its vaccine "is the only ... Until the company has a more promising product in its pipeline, which doesn't center around COVID or seasonal flu infections (where there is plenty ...

GAITHERSBURG, Md., Sept. 4, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that it will ...

Gaithersburg, Maryland-based Novavax received emergency use authorization for its updated COVID-19 vaccine on Aug. 30 and said the vaccine is ready to ship. Novavax received the green light from ...

The updated protein-based vaccine targets JN.1, the parent strain of the most common currently circulating variants. The Food and Drug Administration (FDA) has authorized the emergency use of the ...

Officials at Taiwan-based Bora Pharmaceuticals said the company made a strategic investment whereby Bora Biologics, a wholly-owned subsidiary of Bora and specialist large molecule CDMO, and Tanvex ...